A study to evaluate safety and efficacy of deferasirox in patients with β-thalassemia major

Trial Profile

A study to evaluate safety and efficacy of deferasirox in patients with β-thalassemia major

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Deferasirox (Primary)
  • Indications Beta-thalassaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Nov 2015 New trial record
    • 01 Feb 2014 Primary endpoint (improvement in the severity of liver and cardiac iron overload) has been met, according to results published in the Pediatric Hematology and Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top